Sertraline discontinuation syndrome presenting with severe depression and compulsions.
Benazzi
F
F
D015057:1-Naphthylamine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects* / Q000627:therapeutic use; D003866:Depressive Disorder / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D008875:Middle Aged; D020280:Sertraline; D013375:Substance Withdrawal Syndrome / Q000523:psychology*
D018687:Antidepressive Agents, Second-Generation; D015057:1-Naphthylamine; D020280:Sertraline